Other studies also quantified the profile of E-cadherin expression in CRC patients, albeit without assessing the distribution within the tumor; the results were inconclusive, as some studies showed an advantage in the cytoplasmic localization [17,18], and in others, the membranous distribution of E-cadherin was found to be superior [19]. The gene discussed is CDH1; the disease is neoplasm.